Human immunodeficiency virus infects and replicates in CD4+ T cells but effects on host immunity and disease also involve depletion, hyper-activation and modification of CD4-negative cell populations. In particular, the depletion of CD4-negative γδ T cells is common to all HIV+ individuals. We found that soluble or cell-associated envelope glycoproteins from CCR5-tropic strains of HIV could bind, activate p38-caspases pathway and induce the death of γδ cells. Envelope binding requires integrin α4β7 and chemokine receptor CCR5 which are at high levels and form a complex on the γδ T cell membrane. This receptor complex facilitated V3 loop binding to CCR5 in the absence of CD4-induced conformational changes. Cell death was increased by antigen stimulation after exposure to envelope glycoprotein. Direct signaling by envelope glycoprotein killed CD4-negative γδ T cells and reproduced a defect observed in all patients with HIV disease.
INTRODUCTION
HIV evades the immune response and establishes persistent infection by depleting lymphocyte subsets and altering pathways for cellular maturation or activation [1] . CD4+ T cells are targets for productive virus infection which causes cell death [2, 3] . Other cell subsets can be depleted without productive infection; these include B cells [4] , NK cells [5] [6] [7] , γδ T cells [8] [9] [10] [11] and uninfected, bystander CD4 T cells [12] [13] [14] . Loss of uninfected cells is due to indirect effects of HIV which are important mechanisms for immune deficiency and disease leading to AIDS.
Pathogenesis of HIV and SIV have been linked to increased apoptosis of uninfected cells.
Comparing HIV infection with virulent SIV (rhesus) or non-virulent SIV (African green macaques) showed that apoptosis in CD4+ T cells was an identifying characteristic of pathogenic infections [15] . Sooty mangabeys displayed limited bystander cell killing despite high viremia, consistent with their natural resistance to disease [16, 17] . Increased levels of Fas [18] or PD-1 [19] were associated with cell death or dysfunction. Antibody blocking of Fas ligand [20, 21] or PD-1 [22] slowed disease by preserving CD4+ central memory or CD8+ CTL respectively.
The roles for viral proteins in killing of uninfected, bystander cells are understood poorly.
Previous studies suggested that HIV encodes several apoptogenic proteins with potential to cause cell death, including envelope, Vpr, Tat and Nef [23] [24] [25] [26] , but it is not known whether they are present at sufficient levels in uninfected cells. We do know that envelope is a potent inducer of apoptosis [7, 13, 14, 26, 27] 
but it is not clear how the
For personal use only. on October 31, 2017 . by guest www.bloodjournal.org From protein binds and signals CD4-negative cells which form a significant proportion of cells lost to indirect effects of HIV. Cell depletion through indirect effects (non-infectious mechanisms) is apparent in the loss of phosphoantigen-responsive Vγ2Vδ2+ T cells (also termed Vγ9Vδ2+ T cells in an alternate nomenclature) that normally comprise 1-4% of circulating lymphocytes and 75% of all circulating γδ T cells in healthy individuals [28, 29] . HIV-associated loss of Vγ2Vδ2 cells was postulated to involve apoptosis [30] . In this study, we found that R5 tropic HIV envelope glycoprotein induced significant death of CD4-negative Vγ2Vδ2 T cells. Envelope binding and signaling may be an important mechanism for depleting Vγ2Vδ2 cells during HIV disease.
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MATERIALS AND METHODS

PBMC and tumor cell lines
Whole blood was obtained from healthy human volunteers with written informed consent in accordance with the Declaration of Helsinki; all protocols were approved by the Institutional Review Board at the University of Maryland, Baltimore. Total lymphocytes were separated from heparinized peripheral blood by density gradient centrifugation (Ficoll-Paque; Amersham Biosciences). Peripheral-blood mononuclear cells (PBMC) were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS; GIBCO), 2 mMol/L L-glutamine, and penicillin-streptomycin (100 U/ml and 100 mg/mL, respectively). HeLa and 293T cell lines were cultured in DMEM supplemented with 10% fetal bovine serum (FBS; GIBCO), 2 mMol/L L-glutamine, and penicillinstreptomycin (100 U/ml and 100 mg/mL, respectively). For HeLa cells expressing an R5 tropic HIV envelope (ADA), methotrexate was added to a final concentration of 2 µM.
Reagents
The following reagents were obtained through the AIDS Research 
Statistical analysis
Differences among groups were analyzed by Student's t test. P<0.05 was considered to be significant.
RESULTS
HIV R5-tropic envelope glycoprotein induces Vγ2Vδ2 T cell death
We hypothesized that HIV envelope might play an important role in Vγ2Vδ2 T cell depletion. Vγ2Vδ2 T cells were expanded from healthy donor PBMC after stimulating with isopentenyl pyrophosphate (IPP) plus IL-2 for 14 days and purified by negative selection (Fig. 1A) . Purified Vγ2Vδ2 T cells were treated with two soluble R5-tropic HIV gp120 proteins from the BaL or CN54 HIV strains, and X4-tropic HIV gp120 from the IIIB strain, at 10 µg/ml for 24 hours. Cell death was evaluated by a counting for trypan blue dye negative cells; results were confirmed with flow cytometry for AnnexinV and 7AAD staining on the Vδ2+ population (Fig. 1B, Supplementary Fig. 1 ). R5-tropic HIV gp120 proteins from BaL or CN54 induced significant T cell death. The IIIB-gp120 caused less T cell death than either of the R5 envelopes. CN54-gp120 killed Vγ2Vδ2 cells at concentrations as low as 50 ng/ml ( Supplementary Fig. 2 ).
We next tested the effect of cell-associated HIV (R5-tropic) envelope glycoproteins. Cell Increased cell division and death rates in HIV infection are likely a reflection of persistent immune activation [1, 12] . Activation induced cell death (AICD), implying a role for TCR-dependent antigen recognition, has been proposed to explain cell loss and might be an important mechanism for Vγ2Vδ2 T cell depletion. We tested the effects of HIV envelope on AICD. Vγ2Vδ2 T cells were treated with HeLa cells or HeLa cells expressing HIV envelope (ADA) for 24 hours, then stimulated with the TCR ligand isopentenyl pyrophosphate (IPP). Prior exposure to HIV envelope followed by antigen stimulation, sensitized Vγ2Vδ2 T cells to AICD (Fig. 1E ).
Very high levels of α 4β7 and CCR5 on Vγ2Vδ2 T cells
The mechanisms for binding R5-tropic envelope glycoprotein to CD4-negative Vγ2Vδ2
T cells was unknown before this study. A variety of gp120 receptors and coreceptors have been reported, including CD4, DC-SIGN [31, 32] , Mannose receptor [32] [33] [34] , α 4β7 [35, 36] and CCR5 [37, 38] . We examined expression levels of these receptors by flow cytometry with gating on Vγ2Vδ2 T cells. Vγ2Vδ2 T cells did not express CD4 ( Supplementary Fig. 6 ), but Vγ2Vδ2 T cells expressed β 7 at levels much higher than most CD4 or NK cells (Fig. 2F, Supplementary   Fig. 7 ). High expression of CCR5 is also a feature of Vγ2Vδ2 T cells [39] . We determined the density of CCR5 on Vγ2Vδ2 T cells by comparing with standard cell lines. Surface CCR5 on Vγ2Vδ2 T cells was present at more than 50,000 receptor/cell (Fig. 2H, Supplementary Fig. 8 ). In contrast, CCR5 levels on CD4 T cells ranged from
,000 to 10,000 molecules/cell [42] . Thus, Vγ2Vδ2 T cells have exceptionally high expression of two receptors for gp120, α4β7 and CCR5, despite being negative for CD4.
A fraction of CD4 T cells (Fig. 2F ) also expressed these high levels of β7 [36] . Supplementary Fig. 9 ). To be consistent with cell toxicity assays, we then used culture medium for binding assays, which contains Ca 2+ and Mg
HIV envelope-induced killing of Vγ2Vδ2 T cells depends on
α 4β7 and CCR5 gp120 binding to Vγ2Vδ2 T cells was tested with fluorescein-conjugated R5 tropic gp120 from ADA and YU2 strains. In the absence of divalent cations, which are necessary for full activity of α 4β7 [35], gp120 binds poorly to Vγ2Vδ2 T cells; treating with Ca 2+ or Mn 2+ enhanced gp120 binding (
2+
but we did not supplement divalent cations above their normal levels in medium. These conditions allowed us to detect the binding of gp120 from ADA and YU2 strains to Vγ2Vδ2 T cell surfaces using confocal microscopy ( Fig. 3A) and flow cytometry (Fig.   3B ). YU2-gp120 showed higher binding affinity in these assays than did ADA-gp120 (Fig. 3B) . Consistent with previous reports [43, 44] , soluble CD4 increased the gp120 binding to Vγ2Vδ2 T cells (Fig. 3C ) but there was already substantial binding in the absence of CD4.
To determine whether gp120 binds to both α 4β7 and CCR5, we performed blocking studies. The adhesion molecule MAdCAM1 was used to block α 4β7 [35] and the binding antagonist Maraviroc was used to block CCR5 [45] . Individually, MAdCAM1 or
Maraviroc partially blocked gp120 (YU2) binding to Vγ2Vδ2 T cells (Fig. 3D) . When used together, binding was inhibited by 85% (Fig. 3D) . (Fig. 3E ). MAdCAM1 binding α4β7 or Maraviroc binding CCR5 inhibited cell death; when used together, cell death was inhibited by 90% (Fig. 3F, Supplementary Fig. 10 and 11 ). Specific antibodies against α 4, β 7 or CCR5 also inhibited gp120-induced cell death (Fig. 3F, Supplementary   Fig. 10) . Thus, the maximum γδ T cell death inducible by HIV R5 tropic gp120 depended on binding to α 4β7 and CCR5.
Retinoic acid treatment can be used to increase expression of α 4β7 [35, 46] and CD4-independent binding of gp120 to T cells [35] . We showed that retinoic acid elevated α 4β7 expression on Vγ2Vδ2 T cells (Fig. 3G) . Surprisingly, retinoic acid also increased CCR5 levels ( Fig. 3H ) leading to higher gp120 binding (Fig. 3I ) and gp120-induced Vγ2Vδ2 T cell death (Fig. 3J) . These results support our conclusion that gp120-induced Vγ2Vδ2 T cell death depends on α 4β7 and CCR5, which together bind gp120 efficiently in the absence of CD4. High levels of both molecules on Vγ2Vδ2 T cells explains their susceptibility to gp120-induced killing. 
4β7 and CCR5 form complexes on Vγ2Vδ2 T cells in the absence of CD4
It was reported that CD4 forms complexes with both CCR5 [46] and α 4β7 [36] . Vγ2Vδ2 T cells express high levels of both α 4β7 and CCR5, but lack expression of CD4 (Fig. 2) .
We wondered whether α 4β7 and CCR5 formed complexes on Vγ2Vδ2 T cells. Flow cytometry (Fig. 4A ) and confocal microscopy ( Fig. 4B) revealed the co-localization of α 4β7 and CCR5 on Vγ2Vδ2 T cells (Fig. 4B) . We did not find significant coimmunoprecipitation of β 7 with CCR5 when using a anti-β7 mAb (Fig. 4C, lane 2 (Fig. 4C, lane 3) , indicating that these two receptors exist in close physical proximity on the Vγ2Vδ2 cell membrane.
gp120 V2 and V3 loops mediate binding to Vγ2Vδ2 cells
We had established that gp120 from R5-tropic HIV strains induced γδ T cell death by binding to α4β7 and CCR5 in the absence of CD4. In order to define gp120 structures required for this interaction, we used well-characterized monoclonal antibodies to block binding to γδ T cells. Antibody concentrations were optimized by tittering and testing for maximum inhibition of Env binding. First, we tested antibodies 17b and 48d which recognize epitopes exposed after conformational changes due to gp120 engagement with CD4. Neither 17b nor 48d significantly reduced gp120 binding to γδ T cells, even though adding sCD4 (Fig. 3C ) increased gp120-ADA binding. Next, we tested two potent neutralizing antibodies, b12 and VRC01, which recognize epitopes overlapping the CD4 binding site (CD4bs); they did not block binding or cell killing. Antibodies 697-30D and 447-52D, which recognize gp120 V2 and V3 loops respectively, inhibited both gp120 binding and cell death. The interaction of gp120 with Vγ2Vδ2 T cells was also inhibited by neutralizing antibody 2G12, which recognizes a high mannose carbohydrate cluster.
The non-neutralizing antibody ID6 showed no inhibition of gp120-Vγ2Vδ2 cell interactions, though a polyclonal sheep antiserum against gp120 blocked most of the binding and γδ T cell killing (Fig. 5A and B, Supplementary Fig. 12 ). Since V2 and V3 loops direct binding to α 4β7 [35] and CCR5 [43, 44] respectively, these results support 
gp120-induced Vγ2Vδ2 T cell death depends on a p38-caspase pathway
We next sought to define signaling pathways involved in gp120-mediated and α 4β7/CCR5-dependent Vγ2Vδ2 T cell death. It has been reported that R5 HIV envelope causes a caspase 8-dependent death of CD4 T cells [13, 14] . However, RANTES, the natural ligand for CCR5, triggered killing by cytosolic release of cytochrome c, activation of caspases-9 and -3, and poly (ADP-ribose) polymerase cleavage [47] . In our system, the broad caspase inhibitor Z-VAD completely blocked gp120-induced cell death (Fig. 6A ).
Caspase-8 inhibitor (Z-IETD) showed significant inhibition of gp120-induced Vγ2Vδ2 T cell death, while inhibitors of caspase-2 (Z-VDVAD) and caspase-9 (Z-LEHD) partially inhibited cell death. Inhibitors of caspases 1, 3 or 6 had no effect on cell killing. Consistent with the inhibition experiments, we found that gp120 binding induced the activation (cleavage) of caspase 2, 8 and 9 (Fig. 6B) . We did not find the down-regulation of several anti-apoptotic proteins, including FLIP, Bcl-2 and Bcl-Xl and showed that gp120 binding did not affect their levels (Fig. 6B) . Surprisingly, the activation of caspases by gp120 in Vγ2Vδ2 T cells is Fas-independent. First, a Fas neutralizing antibody did not inhibit gp120-induced cell death, while it blocked activating Fas antibody-induced cell apoptosis (Supplementary Fig. 13A ). Second, gp120 did not change the expression of Fas and FasL on Vγ2Vδ2 T cells (Supplementary Fig. 13B ).
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Fas-independent caspase activation has been reported previously. In many cases, it depends on the activation of p38 MAPK [48, 49] . HIV gp120 induces p38-dependent primary CD4 T cell death and neurotoxicity by binding to CXCR4 or CCR5 [50, 51] . We want to know whether HIV Env-mediated caspase activation and cell death of Vγ2Vδ2 T cells depend on p38 signaling. P38 inhibitor (SB203580) blocked most of Vγ2Vδ2 T cell death (>80%) caused by HIV Env (Fig. 6C) . As a control, inhibition of Akt (LY294002) increased Env-mediated cell death (Fig. 6C) , which is consistent with its anti-apoptotic role as reported previously [52] . Inhibiting other signaling pathways, including Erk (U0126), Ca 2+ (CsA) or NFκB, had no significant effect on HIV Env-mediated Vγ2Vδ2
T cell death (Fig. 6C) . Further, p38 inhibitor blocked both p38 and caspase activation, while caspase inhibitor did not block p38 activation (Fig. 6D) . These findings suggest a novel model for the regulation of caspase during HIV Env-induced Vγ2Vδ2 T cell death based on the sequential activation of p38 MAPK and caspase.
For T cells, and close physical proximity of these receptors increases gp120 binding, p38 signaling and caspase activation. Envelope glycoprotein binding did not require CD4 for efficient interaction with high levels of CCR5, even though CD4 binding is required normally to induce conformational changes which promote CCR5 ligation when chemokine receptor is less abundant on the cell surface [43, 44] .
Indirect cell killing and a role for AICD have been postulated to explain part of the CD4 T cell loss in HIV disease [12] . We propose that envelope-mediated signaling is also responsible for the extensive loss of CD4-negative Vγ2Vδ2 T cells which has been observed in all patients with HIV disease. The complex TCR repertoire of CD4 T cell populations and the potential for direct killing by productive infection makes it difficult to determine the proportion of these cells lost due to indirect effects. Unique features of Vγ2Vδ2 T cells help to show why indirect killing might be responsible for dramatic depletion of this subset that is observed in all patients with HIV disease. γδ T cells in healthy adults comprise 1-4% of circulating lymphocytes and > 75% express the Vγ2- For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
